Loading...
Market
Hims & Hers expands weight loss product range by mid-2025
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Company press releases or major financial news outlets
Story
Hims & Hers Health Adds GLP-1 Injections for Weight Loss, Stock Soars 30%
May 20, 2024, 01:26 PM
Hims & Hers Health has announced the addition of compounded GLP-1 injections to its weight loss program. The news has positively impacted the company's stock, with $HIMS experiencing a significant increase in value. The stock saw a 10% rise shortly after the announcement and later spiked by 20%. By the end of the day, $HIMS was up 30%. This move positions Hims & Hers Health to offer both compounded GLP-1 weight loss treatments and mainstream options, potentially expanding its market reach in a big market.
View original story
Similar markets
Below 5% • 25%
5-10% • 25%
11-15% • 25%
Above 15% • 25%
Top 10% • 25%
Top 25% • 25%
Top 50% • 25%
Below 50% • 25%
0 partnerships • 25%
1 partnership • 25%
2 partnerships • 25%
3 or more partnerships • 25%
Below 50% satisfaction • 25%
50% to 70% satisfaction • 25%
70% to 90% satisfaction • 25%
Above 90% satisfaction • 25%
Below 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
Above 30% • 25%
